GlassScriptPhysician profile
Chintan Pankaj Patel
NPI 1558659441
$13,641.11
in general payments reported to CMS, 2019-2025
36 companies · $2,252 in 2025
The $2,252 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,589 · 2020: $1,382 · 2021: $972 · 2022: $3,289 · 2023: $1,889 · 2024: $2,269 · 2025: $2,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,828 · Travel and Lodging: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,827.75 |
| Travel and Lodging | $582.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,484.90 | 2021-2025 | Onyx Frontier, Abre, Micra |
| Boston Scientific Corporation | $3,008.87 | 2019-2025 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, General - Therapies |
| Abbott Laboratories | $1,538.40 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint, Coroflow |
| Abiomed | $626.32 | 2023-2024 | Impella |
| Amgen INC. | $620.61 | 2022-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $541.60 | 2023-2025 | |
| Heartflow, INC. | $503.15 | 2023-2025 | Ffrct |
| Inari Medical, INC. | $467.07 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Atricure, INC. | $349.78 | 2023-2024 | |
| Shockwave Medical, INC | $325.73 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $315.48 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Pfizer INC. | $299.48 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $176.27 | 2022-2025 | Farxiga, Wainua |
| Medtronic Vascular, INC. | $172.36 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $172.10 | 2022-2024 | Xarelto |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $149.89 | 2022-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $128.53 | 2023-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.57 | 2023-2025 | Jardiance |
| Philips North America LLC | $105.90 | 2023-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided |
| Asahi Intecc USA, INC. | $100.00 | 2024 | Peripheral Vascular |
| Kestra Medical Technology Services, INC. | $65.16 | 2024-2025 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $54.27 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $40.79 | 2023 | |
| Biosense Webster, INC. | $39.45 | 2024 | Carto 3 |
| Kiniksa Pharmaceuticals International, Plc | $39.20 | 2024 | Arcalyst |
| Cleerly, INC. | $33.82 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Imperative Care, INC | $29.67 | 2025 | Symphony Catheter |
| Actelion Pharmaceuticals US, INC. | $27.05 | 2025 | Uptravi, Opsynvi |
| Angiodynamics, INC. | $23.19 | 2024 | Alphavac |
| Lilly USA, LLC | $18.90 | 2025 | Mounjaro, Zepbound |
| Kiniksa Pharmaceuticals, LTD. | $16.31 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $15.67 | 2025 | Optowire |
| Alnylam Pharmaceuticals INC. | $15.29 | 2023 | Amvuttra |
| Impulse Dynamics (USA) INC. | $14.38 | 2025 | Optimizer |
| Thrombolex, INC. | $7.24 | 2024 | Bashir Endovascular Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.71 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chintan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.